Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Review Article

Therapeutic Potential and Clinical Evidence of Hesperidin as Neuroprotective Agent

Author(s): Shivanki Joshi, Ashwani K. Dhingra*, Bhawna Chopra, Kumar Guarve and Deepak Bhateja

Volume 22, Issue 1, 2022

Published on: 23 May, 2022

Page: [5 - 14] Pages: 10

DOI: 10.2174/1871524922666220404164405

Price: $65

Abstract

Background: Neuroprotection is preserving neural function in various neurodegenerative diseases like Alzheimer’s, Huntington’s, Parkinson’s, and multiple sclerosis. Hesperidin, a flavanone glycoside in citrus fruits such as sweet oranges and lemons, possesses many biological effects, including neuroprotection.

Objective: The study aims to explore the neuropharmacological mechanisms and therapeutic potential of hesperidin in the management of neurodegenerative disorders.

Methods: It emphasizes comparative and clinical trial studies with a number of targets reviewed from the data available on PubMed, Science Direct, Clinicaltrails.gov, and from many reputed foundations.

Results: Escalating clinical evidence has established the inhibitory effect of hesperidin in the management of neurodegenerative disorders. Neuroprotective potential of hesperidin is characterized by endogenous antioxidant defence functions, improvement of neural growth factors, antineuroinflammatory activity, and apoptotic pathways.

Conclusion: The present study highlights the beneficial neuropharmacological potential of hesperidin, including anticonvulsant, antidepressant, antioxidant, anti-inflammatory, memory, and locomotor enhancing activities.

Keywords: Hesperidin, neuroprotection, Alzheimer’s, Huntington’s, Parkinson’s, clinical trials.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy